Embla Medical is trading at 34.90 as of the 2nd of December 2024, a 1.97 percent decrease since the beginning of the trading day. The stock's open price was 35.6. Embla Medical has hardly any chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Equity ratings for Embla Medical hf are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of May 2024 and ending today, the 2nd of December 2024. Click here to learn more.
Although Embla Medical's alpha and beta are two of the key measurements used to evaluate Embla Medical's performance over the market, the standard measures of volatility play an important role as well.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Embla Medical stock to make a market-neutral strategy. Peer analysis of Embla Medical could also be used in its relative valuation, which is a method of valuing Embla Medical by comparing valuation metrics with similar companies.